Zobrazeno 1 - 10
of 169
pro vyhledávání: '"Jawad H. Butt"'
Autor:
Kirstyn James, Yasser Jamil, Manish Kumar, Min J. Kwak, Michael G. Nanna, Saadia Qazi, Aaron L. Troy, Jawad H. Butt, Abdulla A. Damluji, Daniel E. Forman, Ariela R. Orkaby
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 15 (2024)
The incidence of frailty and cardiovascular disease (CVD) increases as the population ages. There is a bidirectional relationship between frailty and CVD, and both conditions share several risk factors and underlying biological mechanisms. Frailty ha
Externí odkaz:
https://doaj.org/article/219bc40fcc31410bb0a4f7aadbe29017
Autor:
Jawad H. Butt, Kirsty McDowell, Toru Kondo, Akshay S. Desai, Martin P. Lefkowitz, Milton Packer, Mark C. Petrie, Marc A. Pfeffer, Jean L. Rouleau, Muthiah Vaduganathan, Michael R. Zile, Pardeep S. Jhund, Lars Køber, Scott Solomon, John J.V. McMurray
Publikováno v:
ESC Heart Failure, Vol 11, Iss 1, Pp 65-77 (2024)
Abstract Aims Red cell distribution width (RDW) is a strong prognostic marker in patients with heart failure (HF) and reduced ejection fraction and other conditions. However, very little is known about its prognostic significance in HF with preserved
Externí odkaz:
https://doaj.org/article/cc3942df190d4a5ebb48c652a5cce4f4
Autor:
Pauline Knigge, Sørine Lundberg, Jarl E. Strange, Mariam E. Malik, Nina Nouhravesh, Andrea K. Wagner, Gunnar Gislason, Emil L. Fosbøl, Nicholas Carlson, Deewa Zahir, Charlotte Andersson, Jawad H. Butt, Pardeep Jhund, Mark C. Petrie, John J. V. McMurray, Lars Køber, Morten Schou
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 6 (2024)
Background The incidence and distribution of acute and chronic dialysis among patients with heart failure (HF), stratified by diabetes, remain uncertain. We hypothesized that with improved survival and rising comorbidities, the demand for dialysis wo
Externí odkaz:
https://doaj.org/article/b23f4c07f3714d46b62dc9fc1e7a620e
Autor:
Seiko N. Doi, Jens Jakob Thune, Jens C. Nielsen, Jens Haarbo, Lars Videbæk, Adelina Yafasova, Niels E. Bruun, Finn Gustafsson, Hans Eiskjær, Christian Hassager, Jesper H. Svendsen, Dan E. Høfsten, Christian Torp‐Pedersen, Steen Pehrson, Lars Køber, Jawad H. Butt
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 3 (2024)
Background Patients with heart failure and chronic kidney disease (CKD) may have an increased risk of death from causes competing with arrhythmic death, which could have implications for the efficacy of implantable cardioverter‐defibrillators (ICDs
Externí odkaz:
https://doaj.org/article/0f75628e435748a982c7132d1e95be28
Autor:
Andreas Dalsgaard Jensen, Lauge Østergaard, Jeppe K. Petersen, Peter Graversen, Jawad H. Butt, Henning Bundgaard, Claus Moser, Morten H. Smerup, Ivy S. Modrau, Kasper Iversen, Niels E. Bruun, Christian Torp-Pedersen, Gunnar Gislason, Andrew Wang, Sigurdur Ragnarsson, Jonas A. Povlsen, Lars Køber, Emil L. Fosbøl
Publikováno v:
BMC Cardiovascular Disorders, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background Valve surgery guidelines for infective endocarditis (IE) are unchanged over decades and nationwide data about the use of valve surgery do not exist. Methods We included patients with first-time IE (1999–2018) using Danish nation
Externí odkaz:
https://doaj.org/article/a011a1583f454355a29002e2a76191a8
Autor:
Eva Havers-Borgersen, Anna P. Engelund, Jawad H. Butt, Lauge Østergaard, Lars Køber, Emil L. Fosbøl
Publikováno v:
American Heart Journal Plus, Vol 26, Iss , Pp 100254- (2023)
Introduction: Antibiotic prophylaxis is recommended for patients considered in high risk of infective endocarditis (i.e., patients with prior infective endocarditis, heart valve prosthesis, and certain congenital heart diseases). Methods: This study
Externí odkaz:
https://doaj.org/article/b7818c5d521e4ba7869a4ff5540299c3
Autor:
Morten Malmborg, Ali Assad Turky Al-Kahwa, Lars Kober, Christian Torp-Pedersen, Jawad H. Butt, Deewa Zahir, Christian D. Tuxen, Mikael K. Poulsen, Christian Madelaire, Emil Fosbol, Gunnar Gislason, Per Hildebrandt, Charlotte Andersson, Finn Gustafsson, Morten Schou
Publikováno v:
PLoS ONE, Vol 18, Iss 6 (2023)
Background Whether continued follow-up in specialized heart failure (HF) clinics after optimization of guideline-directed therapy improves long-term outcomes in patients with HF with reduced ejection fraction (HFrEF) is unknown. Methods and results 9
Externí odkaz:
https://doaj.org/article/faa1714aadc942e38a2412c271edd3c6
Autor:
Caroline H. Garred, Deewa Zahir, Jawad H. Butt, Pauline B. Ravn, Jonas Bruhn, Gunnar H. Gislason, Emil L. Fosbøl, Christian Torp‐Pedersen, Mark C. Petrie, John J. V. McMurray, Lars Køber, Morten Schou
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 19 (2022)
Background Guideline‐recommended disease‐modifying pharmacological therapies for heart failure (HF) with reduced ejection fraction are underutilized, particularly among elderly patients. We studied the association of age in adherence and disconti
Externí odkaz:
https://doaj.org/article/b5032302647c4e5180172f269986f45d
Autor:
Asbjørn Ettrup-Christensen, Jawad H. Butt, Mikkel Porsborg Andersen, Maurizio Sessa, Christoffer Polcwiartek, Emil L. Fosbøl, Rasmus Rørth, Søren L. Kristensen, Christian Torp-Pedersen, Lars Køber, Morten Schou, Bhupendar Tayal, Peter Søgaard, Kristian Kragholm
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 10, Iss 9, p 362 (2023)
Introduction: Data on temporal trends in guideline-based medical and device therapies in real-world chronic heart failure (HF) patients are lacking. Methods: Register-based nationwide follow-ups of temporal trends in characteristics, guideline-recomm
Externí odkaz:
https://doaj.org/article/50ab2048e6024b28bf48db691afeab30
Autor:
Jessica T. Huynh, MD, Jeff S. Healey, MD, Kevin J. Um, MD, Maria E. Vadakken, Anand S. Rai, BSc, David Conen, MD, Pascal Meyre, MD, Jawad H. Butt, MD, Hooman Kamel, MD, Seleman J. Reza, BSc, Stephanie T. Nguyen, HBSc, Zardasht Oqab, MD, P.J. Devereaux, MD, Kumar Balasubramanian, MSc, Alexander P. Benz, MD, Emilie P. Belley-Cote, MD, William F. McIntyre, MD
Publikováno v:
CJC Open, Vol 3, Iss 5, Pp 666-674 (2021)
Background: Atrial fibrillation (AF) is frequently reported as a complication of noncardiac surgery. It is unknown whether new-onset perioperative AF is associated with an increased risk of stroke and death beyond the perioperative period. We perform
Externí odkaz:
https://doaj.org/article/2a55ddec8bb6481c9f3a022f5faaf934